Elron Announces Appointment of New Directors

Elron Announces Resignation of Eduardo Elsztain and Saul Zang as Directors

Elron Reports on Court Decision to Approve the Sale of DIC Shares

Elron Announces Appointment of Itzik (Isaac) Idan as Director

Elron Reports On Expiry of External Director’s Term

Elron Reports On Court Decisions Regarding DIC’s Companies

CartiHeal’s Agili-C Implant was Granted Breakthrough Device Designation by the FDA

Elron Reports On Court Decisions Regarding IDB Development

Elron Updates that IDB Development Published An Independent Appraisal of the Company

Elron Announces Agreement for the Transfer of Most of Its Holding In Pocared to Naftali Investments owned by Recanati

Elron CartiHeal-Bioventus Transaction Webinar Translation

Elron CartiHeal-Bioventus Transaction Webinar Replay (in Hebrew)

Elron CartiHeal-Bioventus Transaction Webinar Presentations

Elron to Host a Webinar to Discuss the CartiHeal-Bioventus Transaction

Elron Announces Transaction for an Investment and Option to Sell CartiHeal to Bioventus

Elron Files Immediate Report on Private Offering

Elron Announces that BrainsGate Received CE Approval

Elron Announces Resignation of Eran Saar as Director

Elron Announces Appointment of Niv Levy as CFO

Elron Announces Appointment of Doron Cohen as Director

Elron Files Immediate Report in Response to Publications in the Israeli Media Regarding CartiHeal

Elron Announces Appointment of Yaron Elad as CEO

Elron Announces that BrainsGate Submitted Its PMA Application to the FDA